.png)
Digital Measures for Motor Speech Missions
Welcome to the future of innovation in speech analysis to unlock patient-centric insights !
We are collaborating to further develop a promising, fully automated, remote digital speech solution already proven to work in a clinic setting. We are launching two missions to validate the solution for future regulatory acceptance and use in clinical trials.
Mission 1 - Analytical Validation: Assess performance of a remote, automated measure solution for motor speech biomarkers
We introduce a new, fully automated digital speech biomarker solution that is designed to remotely measure and assess speech patterns in patients with neurodegenerative diseases. DEEP and the mission partners will conduct the research in a modern and highly efficient way. The goal is to generate evidence to assess how the remote solution performs against performance benchmarks, to set the stage for regulatory acceptance and use in clinical trials. We are looking for data and research partners who can benefit from this technology and speech data in an existing trial in exchange for clinical data.
Connect with us to find out more
Mission 2: Clinical Validation: Generate clinical trial results to support clinical interpretation of the digital measure
We aim to gather the necessary clinical evidence to show how these remote, digital assessments can be effectively used in clinical trials and ultimately in everyday clinical practice. This will determine clinical relevance of the measure in relation to other aspects of the disease. We are looking for research partners to utilize this technology and speech data in an existing trial to support measure objectives in exchange for the generated clinical data.
Connect with us to find out more
Benefits of Participation
You gain access to an automated, standardized speech measure solution with co-creation opportunities for use in your future trials
-
Access Digital Speech Measure Technologies
Be among the first to explore and integrate this new, automated speech analysis tool into your trials, enhancing the precision and scope of your clinical studies. -
Remote, Automated Assessments for Clinical Trials
Gain the ability to incorporate remote speech assessments in the future, allowing for more frequent assessments, a broader geographic reach, improved patient convenience, and better data collection efficiency. -
More Objective Speech Measures
Utilize automated, standardized speech measures that reduce variability and provide more reliable clinical data than traditional assessment methods. -
Natively Digital Measurement Pipeline
The adoption of digital speech measures enables faster and more accurate data collection and processing with real-time access to data. -
Assess More Participants, Faster
You will be able to evaluate more trial participants in less time, increasing trial throughput while maintaining high-quality results.
What DEEP Offers
Our missions are designed in collaboration with leading experts and participating companies to ensure they meet the needs of each participant and the healthcare industry.
-
The DEEP services and collaboration tools equip your teams with everything needed to develop digital measures and enable more efficient collaboration along the way.
-
The DEEP digital measure builder, powered by the Stack model, is a framework that can structure your evidence, identify any evidence gaps and facilitates efficient information exchange with regulators. The stack model also promotes reuse of your content and evidence across new solutions or contexts of use.
Join Us on This Journey
Take the lead in digital innovation, join our missions and together we can make a difference in the lives of patients around the world.